{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T02:14:34Z","timestamp":1795054474575,"version":"4.10.2"},"reference-count":54,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,7]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Long telomere length (TL) extends replicative capacity in vitro and predisposes to clonal hematopoiesis. We characterized the cancer phenotype in 51 individuals from 24 families with mutant POT1, a negative regulator of telomerase elongation (median age, 51 years [range, 5-94]). Hematologic malignancies were second in prevalence after melanoma (27%), and lymphoid subsets were more common. They clustered with history of sarcoma, thyroid cancer, and chronic myeloproliferative neoplasms. UK Biobank participants with pathogenic POT1 variants had long TL and higher lymphoid malignancy rates (45% by the age of 80 years; hazard ratio, 8.28; 95% confidence interval, 5.29-13.0). Across cohorts, diagnoses encompassed acute lymphoblastic leukemia and Hodgkin lymphoma in children\/young adults and chronic lymphocytic leukemia\/multiple myeloma in adults. They clustered in families manifesting as autosomal dominant pan-lymphoma with genetic anticipation at times. Lymphocyte TL was longer than granulocytes at baseline (age-adjusted mean +1 kilobase; P&amp;lt; .0001) and was preserved longitudinally with aging. Ultralong lymphocyte TL &amp;gt;99th percentile was more sensitive for identifying pathogenic variants (58% vs 38% for granulocytes). Among asymptomatic POT1 variant carriers, 12 of 20 (60%) had immunophenotype-detected B- and\/or T-cell clonality, with complete penetrance after the age of 65 years (7\/7). IGH CDR3 sequencing supported age-dependent pruning of the B-cell repertoire, and cytogenetic and next-generation analyses uncovered preclinical clonal lymphoma\u2013associated changes in nearly all POT1 variant carriers aged &amp;gt;60 years (9\/10). Our data identify extended cellular longevity due to long TL as an inherited risk factor for lymphoma, explaining its syndromic association with solid tumors and, in some cases, myeloproliferative neoplasms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031287","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T21:53:58Z","timestamp":1769032438000},"page":"2226-2237","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["Lymphoid malignancy and clonality in the POT1-mediated long telomere syndrome"],"prefix":"10.1182","volume":"147","author":[{"given":"Hannah R.","family":"Davidson-Swinton","sequence":"first","affiliation":[{"name":"1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"2Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"3Telomere Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4846-1506","authenticated-orcid":false,"given":"Sheila","family":"Iyer","sequence":"additional","affiliation":[{"name":"1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"3Telomere Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1626-6172","authenticated-orcid":false,"given":"Anna","family":"Kolchinski","sequence":"additional","affiliation":[{"name":"1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7936-7047","authenticated-orcid":false,"given":"Jasmine A.","family":"Salem","sequence":"additional","affiliation":[{"name":"1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"3Telomere Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"DeBoy","sequence":"additional","affiliation":[{"name":"1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"2Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"3Telomere Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Kilada","sequence":"additional","affiliation":[{"name":"1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisoo S.","family":"Hwang","sequence":"additional","affiliation":[{"name":"1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6854-773X","authenticated-orcid":false,"given":"Tania","family":"Jain","sequence":"additional","affiliation":[{"name":"1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"4Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siob\u00e1n B.","family":"Keel","sequence":"additional","affiliation":[{"name":"5Division of Hematology and Oncology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9541-2192","authenticated-orcid":false,"given":"Christopher D.","family":"Gocke","sequence":"additional","affiliation":[{"name":"1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"4Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"6Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2787-1917","authenticated-orcid":false,"given":"Ying S.","family":"Zou","sequence":"additional","affiliation":[{"name":"2Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"6Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5672-533X","authenticated-orcid":false,"given":"Kristen E.","family":"Schratz","sequence":"additional","affiliation":[{"name":"1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"3Telomere Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"4Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Armanios","sequence":"additional","affiliation":[{"name":"1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"2Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"3Telomere Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"4Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"6Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2026050711221206600_bib1","unstructured":"American Cancer Society. Cancer Facts & Figures 2025\n          . . Accessed 12 February 2026. https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/2025-cancer-facts-figures.html."},{"issue":"8","key":"2026050711221206600_bib2","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1182\/blood-2006-06-031948","article-title":"Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)","volume":"109","author":"Wang","year":"2007","journal-title":"Blood"},{"issue":"20","key":"2026050711221206600_bib3","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood-2015-04-537498","article-title":"Familial predisposition and genetic risk factors for lymphoma","volume":"126","author":"Cerhan","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2026050711221206600_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1056\/NEJM199502163320701","article-title":"Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease","volume":"332","author":"Mack","year":"1995","journal-title":"N Engl J Med"},{"issue":"12","key":"2026050711221206600_bib5","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1038\/s41375-022-01711-0","article-title":"Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes","volume":"36","author":"Berndt","year":"2022","journal-title":"Leukemia"},{"issue":"9","key":"2026050711221206600_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428194.2017.1281412","article-title":"Nonrandom occurrence of lymphoid cancer types in 140 families","volume":"58","author":"Jones","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"26","key":"2026050711221206600_bib7","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1056\/NEJMoa2300503","article-title":"Familial clonal hematopoiesis in a long telomere syndrome","volume":"388","author":"DeBoy","year":"2023","journal-title":"N Engl J Med"},{"issue":"9","key":"2026050711221206600_bib8","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1172\/JCI120851","article-title":"Long telomeres and cancer risk: the price of cellular immortality","volume":"129","author":"McNally","year":"2019","journal-title":"J Clin Invest"},{"issue":"5","key":"2026050711221206600_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ccr.2007.02.026","article-title":"Short telomeres limit tumor progression in vivo by inducing senescence","volume":"11","author":"Feldser","year":"2007","journal-title":"Cancer Cell"},{"issue":"23","key":"2026050711221206600_bib10","first-page":"8188","article-title":"Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis","volume":"63","author":"Qi","year":"2003","journal-title":"Cancer Res"},{"issue":"6923","key":"2026050711221206600_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature01385","article-title":"Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing","volume":"421","author":"Wong","year":"2003","journal-title":"Nature"},{"issue":"4","key":"2026050711221206600_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ccell.2023.03.005","article-title":"T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancers","volume":"41","author":"Schratz","year":"2023","journal-title":"Cancer Cell"},{"issue":"5","key":"2026050711221206600_bib13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.2947","article-title":"POT1 loss-of-function variants predispose to familial melanoma","volume":"46","author":"Robles-Espinoza","year":"2014","journal-title":"Nat Genet"},{"issue":"5","key":"2026050711221206600_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.2941","article-title":"Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma","volume":"46","author":"Shi","year":"2014","journal-title":"Nat Genet"},{"key":"2026050711221206600_bib15","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1038\/ncomms9383","article-title":"A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families","volume":"6","author":"Calvete","year":"2015","journal-title":"Nat Commun"},{"issue":"5519","key":"2026050711221206600_bib16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.1060036","article-title":"Pot1, the putative telomere end-binding protein in fission yeast and humans","volume":"292","author":"Baumann","year":"2001","journal-title":"Science"},{"issue":"12","key":"2026050711221206600_bib17","doi-asserted-by":"crossref","first-page":"e107346","DOI":"10.15252\/embj.2020107346","article-title":"Cancer-associated POT1 mutations lead to telomere elongation without induction of a DNA damage response","volume":"40","author":"Kim","year":"2021","journal-title":"EMBO J"},{"issue":"2","key":"2026050711221206600_bib18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1128\/MCB.25.2.808-818.2005","article-title":"Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro","volume":"25","author":"Kelleher","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2026050711221206600_bib19","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ajhg.2024.04.006","article-title":"Telomere-lengthening germline variants predispose to a syndromic papillary thyroid cancer subtype","volume":"111","author":"DeBoy","year":"2024","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2026050711221206600_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jnci\/dju384","article-title":"Germline mutations in shelterin complex genes are associated with familial glioma","volume":"107","author":"Bainbridge","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"6629","key":"2026050711221206600_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1126\/science.abj4784","article-title":"Heritable defects in telomere and mitotic function selectively predispose to sarcomas","volume":"379","author":"Ballinger","year":"2023","journal-title":"Science"},{"issue":"19","key":"2026050711221206600_bib22","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2016-01-695692","article-title":"Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia","volume":"128","author":"Speedy","year":"2016","journal-title":"Blood"},{"issue":"18","key":"2026050711221206600_bib23","doi-asserted-by":"crossref","first-page":"e147598","DOI":"10.1172\/JCI147598","article-title":"Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders","volume":"131","author":"Schratz","year":"2021","journal-title":"J Clin Invest"},{"issue":"5","key":"2026050711221206600_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng.2584","article-title":"POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia","volume":"45","author":"Ramsay","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"2026050711221206600_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","article-title":"Pathogenic germline variants in 10,389 adult cancers","volume":"173","author":"Huang","year":"2018","journal-title":"Cell"},{"issue":"18","key":"2026050711221206600_bib26","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btab051","article-title":"Mutalyzer 2: next generation HGVS nomenclature checker","volume":"37","author":"Lefter","year":"2021","journal-title":"Bioinformatics"},{"issue":"10","key":"2026050711221206600_bib27","doi-asserted-by":"crossref","first-page":"E2358","DOI":"10.1073\/pnas.1720427115","article-title":"Diagnostic utility of telomere length testing in a hospital-based setting","volume":"115","author":"Alder","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2026050711221206600_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.a.10064","article-title":"Telomere length measurements in leukocyte subsets by automated multicolor flow-FISH","volume":"55","author":"Baerlocher","year":"2003","journal-title":"Cytometry A"},{"issue":"4","key":"2026050711221206600_bib29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41416-021-01443-5","article-title":"Association between physical activity, grip strength and sedentary behaviour with incidence of malignant melanoma: results from the UK Biobank","volume":"125","author":"Weber","year":"2021","journal-title":"Br J Cancer"},{"issue":"2","key":"2026050711221206600_bib30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s43587-021-00166-9","article-title":"Measurement and initial characterization of leukocyte telomere length in 474,074 participants in UK Biobank","volume":"2","author":"Codd","year":"2022","journal-title":"Nat Aging"},{"issue":"2","key":"2026050711221206600_bib31","doi-asserted-by":"crossref","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"GigaScience"},{"issue":"16","key":"2026050711221206600_bib32","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2026050711221206600_bib33","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1111\/bjh.17218","article-title":"A rare missense variant in protection of telomeres 1 (POT1) predisposes to a range of haematological malignancies","volume":"192","author":"Nathan","year":"2021","journal-title":"Br J Haematol"},{"issue":"1","key":"2026050711221206600_bib34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41375-021-01335-w","article-title":"Germline POT1 variants can predispose to myeloid and lymphoid neoplasms","volume":"36","author":"Lim","year":"2022","journal-title":"Leukemia"},{"issue":"20","key":"2026050711221206600_bib35","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1073\/pnas.94.20.10827","article-title":"Telomere lengthening and telomerase activation during human B cell differentiation","volume":"94","author":"Weng","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2026050711221206600_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1074-7613(00)80597-X","article-title":"Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential","volume":"9","author":"Weng","year":"1998","journal-title":"Immunity"},{"issue":"6","key":"2026050711221206600_bib37","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1084\/jem.183.6.2471","article-title":"Regulated expression of telomerase activity in human T lymphocyte development and activation","volume":"183","author":"Weng","year":"1996","journal-title":"J Exp Med"},{"issue":"7127","key":"2026050711221206600_bib38","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature05454","article-title":"The POT1-TPP1 telomere complex is a telomerase processivity factor","volume":"445","author":"Wang","year":"2007","journal-title":"Nature"},{"issue":"22","key":"2026050711221206600_bib39","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood.2019003264","article-title":"Cancer spectrum and outcomes in the Mendelian short telomere syndromes","volume":"135","author":"Schratz","year":"2020","journal-title":"Blood"},{"issue":"16","key":"2026050711221206600_bib40","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMc2309139","article-title":"Familial clonal hematopoiesis in a long telomere syndrome. Reply","volume":"389","author":"Armanios","year":"2023","journal-title":"N Engl J Med"},{"issue":"21","key":"2026050711221206600_bib41","first-page":"2002","article-title":"CD5-negative monoclonal B-cell lymphocytosis (MBL) is detectable in 9% of adults aged over 40 but phenotypes associated with clinically common non-Hodgkin lymphomas are infrequent (&lt;2%)","volume":"116","author":"Rawstron","year":"2010","journal-title":"Am Soc Hematol"},{"key":"2026050711221206600_bib42","doi-asserted-by":"crossref","first-page":"2680-2680","DOI":"10.1038\/ncomms3680","article-title":"Using synthetic templates to design an unbiased multiplex PCR assay","volume":"4","author":"Carlson","year":"2013","journal-title":"Nat Commun"},{"key":"2026050711221206600_bib43","doi-asserted-by":"crossref","first-page":"853076","DOI":"10.3389\/fonc.2022.853076","article-title":"Second primary malignancies in patients with melanoma subtypes: analysis of 120,299 patients from the SEER database (2000-2016)","volume":"12","author":"Loya","year":"2022","journal-title":"Front Oncol"},{"key":"2026050711221206600_bib44","doi-asserted-by":"crossref","first-page":"8765369","DOI":"10.1155\/2018\/8765369","article-title":"Incidence of second malignancy in patients with papillary thyroid cancer from surveillance, epidemiology, and end results 13 dataset","volume":"2018","author":"Endo","year":"2018","journal-title":"J Thyroid Res"},{"issue":"6","key":"2026050711221206600_bib45","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/leu.2016.20","article-title":"Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV","volume":"30","author":"Miranda","year":"2016  26","journal-title":"Leukemia"},{"issue":"33","key":"2026050711221206600_bib46","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1200\/JCO.2010.29.1112","article-title":"Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype","volume":"28","author":"Morton","year":"2010","journal-title":"J Clin Oncol"},{"issue":"26","key":"2026050711221206600_bib47","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin's lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"2026050711221206600_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.2843","article-title":"A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia","volume":"46","author":"Speedy","year":"2014","journal-title":"Nat Genet"},{"key":"2026050711221206600_bib49","doi-asserted-by":"crossref","first-page":"14517","DOI":"10.1038\/ncomms14517","article-title":"A genome-wide association study yields five novel thyroid cancer risk loci","volume":"8","author":"Gudmundsson","year":"2017","journal-title":"Nat Commun"},{"key":"2026050711221206600_bib50","doi-asserted-by":"crossref","first-page":"26037","DOI":"10.1038\/srep26037","article-title":"Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma","volume":"6","author":"Ge","year":"2016","journal-title":"Sci Rep"},{"issue":"11","key":"2026050711221206600_bib51","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ng.959","article-title":"Genome-wide association study identifies three new melanoma susceptibility loci","volume":"43","author":"Barrett","year":"2011","journal-title":"Nat Genet"},{"issue":"9","key":"2026050711221206600_bib52","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ng.3373","article-title":"Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma","volume":"47","author":"Law","year":"2015","journal-title":"Nat Genet"},{"issue":"7","key":"2026050711221206600_bib53","doi-asserted-by":"crossref","first-page":"e13874","DOI":"10.1111\/acel.13874","article-title":"Association between genetically determined telomere length and health-related outcomes: a systematic review and meta-analysis of Mendelian randomization studies","volume":"22","author":"Chen","year":"2023","journal-title":"Aging Cell"},{"issue":"14","key":"2026050711221206600_bib54","doi-asserted-by":"crossref","first-page":"eabl6579","DOI":"10.1126\/sciadv.abl6579","article-title":"Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential","volume":"8","author":"Nakao","year":"2022","journal-title":"Sci Adv"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/19\/2226\/2517476\/blood_bld-2025-031287-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/19\/2226\/2517476\/blood_bld-2025-031287-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:22:25Z","timestamp":1778167345000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/19\/2226\/566170\/Lymphoid-malignancy-and-clonality-in-the-POT1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":54,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,5,7]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031287","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,7]]},"published":{"date-parts":[[2026,5,7]]}}}